Prosight Management, LP Baxter International Inc Transaction History

Prosight Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$53.86 - $66.8 $2.1 Million - $2.61 Million	39,000 New	39,000 $2.1 Million
Q2 2021 Aug 13, 2021	SELL	$80.5 - $88.01 $466,900 - $510,458	-5,800 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$76.38 - $86.03 $8.8 Million - $9.92 Million	-115,275 Reduced 95.21%	5,800 $489,000
Q4 2020 Feb 12, 2021	SELL	$75.39 - $82.36 $69,735 - $76,183	-925 Reduced 0.76%	121,075 $9.72 Million
Q3 2020 Nov 13, 2020	BUY	$78.33 - $90.73 $6.23 Million - $7.21 Million	79,500 Added 187.06%	122,000 $9.81 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $3.34 Million - $4 Million	42,500 New	42,500 $3.66 Million

1,007

450M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $14.9B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

Stay updated on Prosight Management, LP with notifications on news.